{"name":"ZSky Biotech Inc","slug":"zsky-biotech-inc","ticker":"","exchange":"","domain":"","description":"ZSky Biotech Inc is a biotechnology company focused on developing innovative personalized cancer vaccines. The company's lead product, Personalized Dendritic Cell Vaccine ZSNeo-DC1.1, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTFhvZmdzNU9VZlBXSmt0Z0dxRnY2d0RDOHdDSzNIX0lETk0yMWtxRFc5aXAyTm9LNUxfVHNpSUJJX25Zcjd4ZVU1RmFiQjBuZXdoTVhvYjFJelZaYXJENEY2NVh4TC0zUGcxS1dCaHdldHVkYmNEN0tSQnJIcmx2WVR1bVU0WkZfWkJuT0VoM0JEdzliY1hRaHRIVQ?oc=5","date":"2026-03-27","type":"regulatory","source":"Pharma Voice","summary":"Novo’s FDA voucher victory; biotech’s rigid glass ceiling - Pharma Voice","headline":"Novo’s FDA voucher victory; biotech’s rigid glass ceiling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOa05VZ1RGb3ZwLWpqNDBfZ2lsdkoyNGFUVjNNUFJVVXZ3b1o2RkhHVGN6NkVEU0dGWGI0YWQ5UnB6U1N0WUo2dk5kZU9TZmJVOFhibW9sY1k2cGwtVjJvdUh5NmllNUc5ZmRvQ1pTSnl6TmdKbVNnVHZtVzFXTWJYZ2MzRFotNVhrQWhNbWdnMmhiVnp6RnRuR0dGc3UyeUJoTkZrbXRGa3VjbGc?oc=5","date":"2026-03-24","type":"pipeline","source":"Benzinga","summary":"NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Benzinga","headline":"NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdG8ybnJoZ1BXeUk4ZG9uUGxiRlZIQUVYdjd3djZ1Y1ZoX3hPcHlDMGZsSG9jYmZ1V0R6X29zU1RKdmNuUlpOVEVyQWJZWlVRWFNGUU1SOEstUXJHUGFYa0VTS29DelFRTXdwTXc4T2tOWjRyNS1kaWRzRndXV0IydGlJTWpWTDRoWEFYNTdlMFhGTFdsajR6ZlI4YWNjRHBE?oc=5","date":"2026-03-11","type":"pipeline","source":"Fierce Pharma","summary":"Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales - Fierce Pharma","headline":"Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQRk90RUNCOXNlREczcjZLQ09tSXk0VGxNSXpzRU5OUFhERC1fVWF1eXM3VEI3Z0wyLS1FclVEX1hKTnFSMWN3c2NPRnRDZUlLWkdYb2ZENkpWQzhEUnpra3JpNFBlay1xMVpVZWozSjJObEU3ZE0tUHZZMFV3RTl1eG5RSmFCcUpjcmJQT3RGM2xkUFkxVk0taVpDQXR1Zi03WGt0T01sT2UxUXRVZDM3Y0xzbDhrT2gwajhzY2c1VHdMTTk1UzdKaVVjUEpyczNSQS05OFJwUUF4WFh4QTFmNGx6d0xpZ1FnSVF4SDhLRnM1ZW9TSTJjUkVoTnY5WU9xQmVsUE4wT0Rva1FMdDkydENBdGRnQQ?oc=5","date":"2026-03-10","type":"pipeline","source":"PR Newswire","summary":"Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease - PR Newswire","headline":"Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntingt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOTHdnOEl1a3AyeXJlSUlERFM4dEdZMU1VU2c2ZHFXNVJuWlB1ZDhKY3ZpcENlbEx3YVdFdnVkV2VxOWNTdGZ6b3VKMXpwQU82R2dqdDRvdkdKYkZzNElzYXJoOVhIc25Rbzg2SzVCNl9SQV9ieVpveDFXY2prSXkzaGhDblhpZWNWaGtteUMxU3RQQ09tSmJRV3Aya0J2TG95ck9NRVlnYXMzY1BXeERWMWNJbk00ZkRxN2VOQ0RRMFBBNjJ2bnhSSy1qQQ?oc=5","date":"2026-02-06","type":"pipeline","source":"BioSpectrum Asia","summary":"Sky Labs inks distribution agreement with Otsuka Pharma for 'CART BP pro' in Japan - BioSpectrum Asia","headline":"Sky Labs inks distribution agreement with Otsuka Pharma for 'CART BP pro' in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxONWZKUlA2WjktMm96VlRzdFhIX2lCY1BwcU1XNjZ2WGdtTDFKWkVMSDBzbUtHOEhqc2hxMGtlT0lDMDdjc1ZOaklmRnNEUndvWEkwYm9rdnF6NEF1NFNBNWhhajVvMWk1c1dWZk1tOElVMVR1OWVvWVpMV08yMHlJT3ppLXBKS1BKdzNnR293allEN1NTUGVRVHNDaThkS3hhWm9iRDVUV2I5Q0Q4WjFlSTduWUkxdkhpVlpvbHp4S1I4MXBFMi1rSjlKXzQtbGhWdUxPVFpQSDRIam1uQUQ0U0xTcDNaV1NJMmozZzdXbk1ubUJYdjRfVm9SYmQwMHBPVGhFdlE3THQ2VGtqYWdCSjZYeXliUERUX1FQSlFvSzNJTF94UzBrZGpYTE9LcmE1TG9Oa2FhcnE?oc=5","date":"2026-01-27","type":"trial","source":"PR Newswire","summary":"Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease - PR Newswire","headline":"Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a T","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-19","type":"pipeline","source":"simplywall.st","summary":"Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift - simplywall.st","headline":"Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFAzZW80M2NsY0p5RFR0Nk53dWxxNVJtVkQwMGs1MU1nenROXzl0cWFVRURGQ240MmRtV0o1S0pIQ0VVZVRRQW1OV0UyTlNHTUNCYmVtaVdEM0VLM2pHOTBEUkt3V1EyVXVvazR2OWxxbDhSaHliTUdZeFZXN18?oc=5","date":"2025-12-17","type":"deal","source":"BioSpace","summary":"The 7 Most Impactful M&A Deals of 2025 - BioSpace","headline":"The 7 Most Impactful M&A Deals of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPZVJZTlFEUU5sREVKbkdiQ2hzOG5xUTNheUpWUDBqQ0dUcWhBX21VdThGSFNLTFVtSGFMM1dNZEZqazhJM2FqeUlwTmdNekp5TFlJT1NuaS1qaEQtSnRMU1FPY3VHd0lFOXExTldWWjhVcTlDenFmQlpXcGVLRTZKZjdLUHc?oc=5","date":"2025-10-31","type":"pipeline","source":"Financial Times","summary":"Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid - Financial Times","headline":"Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPaC1SSi1STlI4WlBuOFZ5dEJWNl9HRXhpS0E3dWFWdGVqMldhZVp4ZFIyUnVnYzJqSTFIYmF4LS0zbXJzRG8xakQ2NVJsRmtrTC10aHFhcmV4ck9PUk5Fakg3M19TRFlUaDFPa0F4eGlYVWVCY3AxZ0VCNlpPQko3NG84UDNSMkpwdEl4eW9fM2gyRkkyajZleQ?oc=5","date":"2025-10-06","type":"trial","source":"BioPharma Dive","summary":"Skye shares crash as obesity drug falls short in key study - BioPharma Dive","headline":"Skye shares crash as obesity drug falls short in key study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxOYVlhT0F1ZXBEc0JwSXl1SWxNLWVaa3NfbDEyTU5yc0YzVklTY2w0dGdqOWlGcTBDSjBrQ1BnbDJROVZoOHdIWVVIMGM4SUlYUEdDUGpfcmRWQXl4ZWZubE90b3FiaVJwVlBQRjJfcVRHWW4zTlBTTndaRVRpeXRWa0VyTzBIRTY5cUlOX1dDUzJFcm5mSk9ONjJOR1B6Ql9VSnBMS1ZYLTBod0RQWTVfSUJxUzlfQ1lSRFlfMHVHZzVFSkxBWWVsZk1fVlV6cUxOaldtbDdnRmZYUGhJMVlzSkdZb1I1a1QtNmhaM3NKanBIY3d2TTBnczRsYVByZUxPUjkxRUtfT1ZqVTFhUGJ1OS1zV0ZDVm1kR19meGlSanNseWVLM3FHaW9ZUndOLTVjY1YyMkJ0MksyV2lQelJMVE5PR0FTaW41aFBiMHJ5cGZBX0ZGSUlObHhYXzh2cUltanBSNkEyQnVEdldr?oc=5","date":"2025-09-11","type":"pipeline","source":"GlobeNewswire","summary":"Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,0","headline":"Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxORjNQV2JDSGt4UEtBeU1YR29JcHdlV1VlMDVGcnJhLS0xbTFpSXVHd2tZVjJwazh4SXRRUmF0V0FWQU9yOGxIUVdwTEkxNjNlQlUzdDRoV1JrNHVYSXZiM3pORnRiMHcxNzVtc3dFLXVYUmc4THpUbkRRZl9wYlB2dG0wVTdsR0FLZzlUdDBWbjllemlpWkVuMkdydWI4YTBHNWc?oc=5","date":"2025-06-04","type":"pipeline","source":"Sky News","summary":"Biotech king Evans lands $50m injection for Ellipses cancer drugs - Sky News","headline":"Biotech king Evans lands $50m injection for Ellipses cancer drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}